Yahoo!
My Yahoo!
Mail
Sign In
[New User?
Sign Up
]
Finance Home
|
Help
Wednesday, February 10, 2010, 8:49am EST - Canadian Markets open in 41 minutes.
To create a watchlist or portfolio of shares,
Sign-in
or
Register
Finance Home
Investing
Volume Leaders
Local Markets
US Markets
International Markets
Advances & Declines
ETFs
Income Trust News
News & Opinion
Markets
Industry
RSS-My Yahoo!
Personal Finance
Banking & Budgeting
Calculators
Insurance
Retirement
Taxes
My Portfolios
Sign In to Create/Edit My Portfolios
Get Quotes
Symbol Lookup
Exchanges
(CGRB)
On Dec 31:
0.00 USD
0.00 (0.00%)
MORE ON CGRB
Quotes
Summary
Options
Historical Prices
Charts
Interactive
Basic Chart
Technical Chart
News & Info
Headlines
Company Events
Company
Profile
Key Statistics
SEC Filings
Competitors
Industry
Analyst Coverage
Analyst Opinion
Analyst Estimates
Research Reports
Star Analysts
Ownership
Major Holders
Insider Trans.
Insider Roster
Financials
Income Statement
Balance Sheets
Cash Flow
(NGM:CGRB) Delayed quote data
Last Trade:
0.00 USD
Trade Time:
Dec 31
Change:
0.00 (0.00%)
Prev Close:
N/A
Open:
N/A
Bid:
N/A
Ask:
N/A
1y Target Est:
39.00
Day's Range:
N/A - N/A
52wk Range:
16.35 - 45.00
Volume:
0
Avg Vol
(3m)
:
435,814
Market Cap:
N/A
P/E
(ttm)
:
N/A
EPS
(ttm)
:
N/A
Div & Yield:
N/A (N/A%)
1d
5d
3m
6m
1y
2y
5y
Add CGRB to Portfolio
Download Data
HEADLINES
[$$] JNJ Preview: Medical Devices Should Be the Highlight
at RealMoney by TheStreet.com
(Mon, Oct 12)
COUGAR BIOTECHNOLOGY, INC. Files SEC form 8-K, Changes in Control or Registrant, Change in Directors or Principal Off
EDGAR Online
(Thu, Jul 9)
[video] China Watch: Yongye Biotechnology
at TheStreet.com
(Wed, Jun 17)
COUGAR BIOTECHNOLOGY, INC. Files SEC form 8-K, Other Events
EDGAR Online
(Mon, Jun 1)
OncoGenex Prostate Drug Extends Survival in Study
at TheStreet.com
(Sat, May 30)
Study: OncoGenex Prostate Drug Extends Survival
at TheStreet.com
(Sat, May 30)
OncoGenex Prostate Drug Extends Survival
at TheStreet.com
(Sat, May 30)
This Company Is Hot and Going Places
at Motley Fool
(Fri, May 29)
Pharma's Feeding Frenzy
at CNBC
(Thu, May 28)
COUGAR BIOTECHNOLOGY, INC. Files SEC form 8-K, Entry into a Material Definitive Agreement, Financial Statements and E
EDGAR Online
(Wed, May 27)
More Headlines for CGRB...
ANALYST
EPS Est (next year)
(Dec-09)
:
N/A
EPS Est (in 2 years)
(Dec-10)
:
N/A
Avg Rec (current)*:
3.0
PEG Ratio:
N/A
* (Strong Buy) 1.0 - 5.0 (Strong Sell)
Analyst Opinion
-
Estimates
BUSINESS SUMMARY
No business summary available for CGRB.
Add to Portfolio
Email to a Friend
Get
Summary
for Another Symbol:
Symbol Lookup
Latest News
Canadian Indices